sur Quantum Biopharma Ltd.
Quantum BioPharma Sues Over Alleged Stock Manipulation
Quantum BioPharma Ltd. (NASDAQ:QNTM) has filed a lawsuit in the United States District Court, alleging that CIBC World Markets, RBC Dominion Securities, and others manipulated its stock price through spoofing. The complaint claims these actions occurred between January 2020 and August 2024, resulting in damages exceeding $700 million USD.
The company asserts that the defendants repeatedly engaged in spoofing tactics, artificially depressing its stock price and harming investors. Stock prices dropped from over $460 USD in January 2020 to $7.55 USD by October 18, 2024. Legal representation will be provided by Christian Attar and Freedman Normand Friedland LLP, working on a contingency basis.
Quantum BioPharma remains open to dialogue for a resolution while investigations continue to identify other potential offenders. Additional information, including a copy of the complaint, is available on the company's website.
R. P.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Quantum Biopharma Ltd.